2023-09-08 17:18:18 ET
More on Catalyst Pharmaceuticals
- Seeking Alpha’s Quant Rating on Catalyst Pharmaceuticals
- Historical earnings data for Catalyst Pharmaceuticals
- Financial information for Catalyst Pharmaceuticals
- Catalyst Pharmaceuticals: The Journey From Earnings Euphoria To Patent Perils
- Catalyst Pharmaceuticals Q2 2023 Earnings Call Transcript
- Catalyst Pharmaceuticals: Expecting Higher FIRDAPSE Revenues In A Year
- Catalyst Pharmaceuticals: A New Catalyst Tilts The Scales - Just Barely
- Catalyst Pharma announces retirement of CEO
- Catalyst in licensing deal with Santhera for Duchenne candidate
For further details see:
Catalyst Pharmaceuticals launches $500M mixed shelf offering - filing